Suresnes

Location

France

Year of acquisition

2017

Former use

Pharmaceutical activities

Size

0.5 Ha

Redevelopment

11,000 sqm

Program

Residential and office building

Status

Development

In October 2017, Ginkgo acquired the headquarters of pharmaceutical company Mylan France in Suresnes, which is part of the Greater Paris Metropolis.

Used oil pollution has been identified locally in soils requiring offsite treatment. In addition, asbestos was identified in the existing buildings. Complete cleaning and removal of asbestos and fuel tanks were undertaken, while 90% of non-hazardous demolition waste was recycled off-site.

The project involves a complete renovation and extension of the historic building to provide 6,600 sqm of offices and 4,900 sqm of housing.

The project contributes to carbon footprint reduction by conserving the existing structure of 4,600 sqm. It targets the following certifications (i) HQE level High Performance, (ii) BREEAM level Very Good, (iii) OSMOZ (office users well-being), and (iv) BiodiverCity.